×

Neville Registrars is delighted to welcome Redhall Group plc as the newest addtion to its list of client companies.

Redhall is a multi-disciplined engineering business offering design, manufacture, installation, maintenance and decommissioning services to the nuclear, oil & gas, defence, petrochemical and food process sectors.

The Redhall Group consists of Manufacturing, which encompasses Booth Industries, Jordan Manufacturing and R Blackett Charlton and Specialist Services.

Further information can be found on the Company's website: http://www.jordanmanufacturing.co.uk/index.php

Close

×

Neville Registrars is delighted to welcome Bricklane Residential REIT PLC as the newest addtion to its list of client companies.

 

Close

×

RNS Number : 4957K

Veltyco Group PLC

22 September 2016

 

22 September 2016

Veltyco Group PLC

("Veltyco" or "the Group")

Marketing Agreement with ZoomtraderGlobal

 

Veltyco Group plc (AIM:VLTY), the online marketing company in the gaming, lottery and binary options businesses, is pleased to announce that its subsidiary Options888 Marketing Ltd ("Options888") has entered into a marketing and revenue sharing agreement (the "Marketing Agreement") in respect of the domain ZoomtraderGlobal (www.zoomtraderglobal.com) ("ZoomtraderGlobal") with Novox Capital Limited ("Novox").  Novox is a Cyprus Securities and Exchange Commission (CySEC) investment firm and the owner and operator of the domain. 

ZoomtraderGlobal is an option trading platform that is designed to be easy to use and gives traders the ability to trade stocks, currency pairs, commodities and indices on the options market together with money management features that the Directors' believe are unique in the field.   ZoomtraderGlobal offers comprehensive customer support, enabling the provision of quality services.

The Marketing Agreement grants Options888 exclusive marketing rights and a participation in revenue generated by all new customers to ZoomtraderGlobal.

In addition, Novox has assigned to Veltyco the benefit of an option agreement with Elsona Assets Limited ("Elsona") to acquire ZoomtraderGlobal.  It is not the current intention of Veltyco to exercise the option.

As consideration for the Option Assignment and procuring entry into the Marketing Agreement, the Company has allotted and issued to DTIG Holding Limited ("DTIG"), a subsidiary of Elsona, and applied for the admission to trading on AIM of, 10,688,000 new ordinary shares ("New Shares") in the Company. Trading of the New Shares is expected to commence on or around 27 September 2016 ("Admission"). Following Admission, the Company's issued share capital will consist of 67,626,260 ordinary shares ("Ordinary Shares"), with no Ordinary Shares held in treasury. Therefore, shareholders may use the above figure of 67,626,260 Ordinary Shares as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in Veltyco under the FCA's Disclosure and Transparency Rules. Furthermore, a return on the revenue generated under the Marketing Agreement of up to €50,000 per month will be payable to Elsona for an initial lead-in period of 12 months or until the aggregate sum of returns paid equals €600,000.  

Ilan Tzroya, Brand Manager of ZoomtraderGlobal, commented: "We are very excited to partner up with Veltyco Group, benefiting from all the marketing experience available in the group. We are committed to driving these revenue sharing opportunities and confident that this will be a major success."  

David Mathewson, Chairman of Veltyco Group plc, commented: "We are very pleased to have secured this agreement with ZoomtraderGlobal who are bringing new and exciting trading options to its customers though a strong and experienced team.

This agreement brings a great opportunity for Veltyco to significantly increase its revenues through customer referrals to ZoomtraderGlobal from our focussed marketing campaign.  We look forward to growing this relationship."

 

For further information, please contact:

Veltyco	+ 44 (0)16 2464 7979
David Mathewson, Chairman     Marcel Noordeloos, CFO
Stockdale Securities	+44 (0)20 7601 6100
Antonio Bossi David Coaten
IFC Advisory (Financial PR)	+44 (0)203 053 8671
Graham Herring Tim Metcalfe Heather Armstrong

 

About Veltyco

Veltyco is a holding company primarily focused on generating marketing leads and entering into marketing contracts for the activities of its partners in sports betting, casinos, poker games, lottery and binary options, such as Betsafe (online casino and sports betting), Lottopalace (lottery) and Option888 (binary options). Veltyco focuses on all of these three complementary activities under one umbrella, leveraging its historical cash generative activities of marketing online casinos and sports betting.

Website: http://www.veltyco.com/

 

About ZoomtraderGlobal

ZoomtraderGlobal is owned and operated by Novox Capital Ltd, a Cyprus Investment Firm ("CIF"), registered under the laws of The Republic of Cyprus, with registration number HE292182. Novox Capital Ltd is licensed and regulated by the Cyprus Securities and Exchange Commission (CySEC), under the license number 224/14.

 

The Novox's license is subject to the Cyprus Investment Services and Activities and Regulated Markets Law of 2007, which harmonized the relevant laws of the Republic of Cyprus with the requirements of the European Parliament's Markets in Financial Instruments Directive (MiFID) to ensure a high level of protection for investors. This is a guarantee that the services received from the Company comply with all the applicable regulations.

 

ZoomtraderGlobal is authorized to operate throughout the EU, reflecting its steadfast commitment to creating a safe, responsible and regulated trading environment for all its clients.

Website: https://www.zoomtraderglobal.com/

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCLBMFTMBTTBTF

Close

×

RNS Number : 3788K

Concepta PLC

21 September 2016

 

21 September 2016

Concepta plc ("Concepta" or the "Company")

New laboratory opening

 

Concepta plc (AIM:CPT), the UK healthcare company targeting the personalised mobile health market with a primary focus on women's fertility, announces that it has moved its UK laboratory operations to a new site, at Colworth Park in Bedfordshire, doubling the size of its operational headquarters.  This new laboratory opening is in line with the Company's strategy of increasing its operational capacity and economies of scale as it moves towards launching its My Lotus product for unexplained infertility* into China in H2 2016 and, following CE marking, into the UK and Europe in 2017.

 

The state of the art laboratory will house four employees in R&D and another two employees in Quality Assurance. In addition, a separate area for assembly can accommodate a further ten people producing testing strips for Concepta's 'MyLotus' meter. Aside from manufacture, assembly and testing, the lab will primarily be used as a research and development hub for My Lotus product enhancements and new product development.

 

Commenting on the opening of the new facility, Erik Henau, Concepta CEO said: "Following our highly successful AIM listing in July 2016, this new laboratory is a key part of the Company's growth strategy and extends both its capacity and capabilities as we begin the process of launching our proprietary product into China prior to a European launch in 2017. Concepta's research team will be working in the new lab effective immediately to accelerate new product development, both within our core business area of fertility as well as other areas in the wider mobile health space.  We look forward to updating the market on these exciting developments in due course."

 

ENDS

 

Enquiries:

The Company

Adam Reynolds, Chairman

Tel: +44 (0) 7785 908158

 

SPARK Advisory Partners Limited (Nomad)

Neil Baldwin/Mark Brady

Tel: +44 (0)20 368 3550

 

Beaufort Securities Limited (Broker)

Jon Belliss

Tel: +44 (0)20 7382 8300

 

Yellow Jersey PR Limited (Financial PR)

Felicity Winkles/ Joe Burgess/ Josh Cole

Tel: +44 (0) 7748 843 871

 

About Concepta Plc:

Concepta plc is a pioneering UK healthcare company that has developed a proprietary platform and products targeted at the personalised mobile health market with a primary focus on women's fertility and specifically unexplained infertility*.

 

Founded in 2013, Concepta has developed a revolutionary flagship product 'MyLotus' for home self-testing that helps women with unexplained infertility to conceive.  

 

MyLotus is the only consumer product which allows both quantitative and qualitative measurements of measurement of a woman's personal hCG and LH hormone levels in an easy to use home test to facilitate higher conception rates and early diagnosis of any fertility problems.  Competitor products currently only allow qualitative measurement and are based on the 'average woman'.  

 

Concepta has a defined route to market for its new 'My Lotus' product with Regulatory approvals for launch in China in place for 2016 and CE-Marking for UK and Europe to follow in 2017 where the revenue potential of the Chinese and EU infertility market is worth c.£600m per annum for the company.

 

*Unexplained infertility refers to women that have been unable to conceive after 6 months of trying. This highly motivated target group of consumers won't typically be offered medical intervention until 12 months of unsuccessfully trying, with IVF not offered until two years. Research indicates couples start to take positive action ahead of this time and there is little medical support to help them do so.

 

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

NRALLFVDATIIFIR

Close

×

RNS Number : 3827K

Midatech Pharma PLC

21 September 2016

 

21 September 2016

 

 

Midatech Pharma PLC

("Midatech" or the "Company")

 

Midatech Pharma US Announces Partnership with R-Pharm US to Co-promote Zuplenz® (ondansetron) oral soluble film and Oravig® (miconazole) orally-dissolving buccal tablet

 

~ Partnership provides additional reach and frequency within the oncology market ~

~ Deal broadens Zuplenz and Oravig account call points ~

 

Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products in oncology, immunology and other therapeutic areas, today announced that its US subsidiary, Midatech Pharma US, has finalised a co-promotion agreement with R-Pharm US LLC providing additional reach and frequency for the promotion of Zuplenz and Oravig to oncology accounts across the US.

 

Under the terms of the agreement, R-Pharm will promote Zuplenz and Oravig in accounts that are not currently in the Midatech Pharma US call universe as well as provide additional promotion in accounts where Midatech currently markets its oncology supportive care product portfolio.

 

David R. Benharris, President of Midatech Pharma US, said: "We are extremely excited to add a valued partner in R-Pharm, who can provide additional promotional reach into new accounts as well as supplemental frequency to additional call points in our targeted offices. Our products, as with many pharmaceuticals products, are detail sensitive. The partnership with R-Pharm provides an enriched share of voice to further bolster our ongoing commercial efforts for both Zuplenz and Oravig."

 

Mark Pavoa, President and Chief Executive Officer of R-Pharm US, said: "Zuplenz and Oravig are complementary to our oncology franchise, which includes Ixempra®. Cancer patients and treatment teams face many challenges as they battle the disease, and we are proud to represent these two additional potential solutions."

 

Demetrios Kydonieus, President and Chief Business Officer of R-Pharm US, commented: "Adding Zuplenz and Oravig to our existing portfolio allows us to leverage our commercialisation investment and to increase the value we bring to patients and the medical offices we serve."

 

Zuplenz is the only oral soluble film formulation of the 5-HT3 receptor antagonist ondansetron, indicated for the prevention of nausea and vomiting associated with the use of highly and moderately emetogenic cancer chemotherapies, radiotherapy, and in postoperative patients.

 

Oravig is the only once-daily local therapy available for treatment of oral thrush in adults. All other currently marketed, localised therapies for oral thrush require patients to take/administer their treatment a minimum of four times daily.

 

R-Pharm will begin promoting both Oravig and Zuplenz in January of 2017.

 

– ENDS –

 

For more information, please contact:

 

Midatech Pharma PLC

Jim Phillips, CEO

Tel: +44 (0)1235 888300

www.midatechpharma.com

 

Panmure Gordon (UK) Limited (Nominated Adviser and Broker)

Corporate Finance

Freddy Crossley / Atholl Tweedie / Duncan Monteith

Corporate Broking

Tom Salvesen

Tel: +44 (0)20 7886 2500

 

Consilium Strategic Communications (Financial PR)

Mary-Jane Elliott / Ivar Milligan / Matthew Neal / Hendrik Thys

Tel: +44 (0)20 3709 5700

Email: midatech@consilium-comms.com

 

Westwicke Partners (US Investor Relations)

Chris Brinzey

Tel: +1 339 970 2843

Email: chris.brinzey@westwicke.com

 

Notes for Editors

 

About Midatech Pharma PLC

Midatech is an international specialty pharmaceutical company focused on oncology and other therapeutic areas with a commercial platform and four marketed products in the US. Midatech's strategy is to develop products in-house in oncology and with partners in other indications, and to accelerate growth organically and through strategic acquisitions. The Company's R&D activities are supported by two breakthrough drug delivery technologies. The Group, listed on AIM: MTPH and Nasdaq: MTP, employs c.100 staff in four countries. For further company information see: www.midatechpharma.com

 

About R-Pharm US

R-Pharm US is a fully integrated specialty pharmaceutical company focused on the development and commercialization of medicines to treat cancer and chronic immune diseases. For further company information see: www.rpharm-us.com

 

For full prescribing information, including approve indications, potential side effects and other warnings on Ixempra, please visit www.ixempra.com

 

Forward-Looking Statement

Certain statements in this press release may constitute "forward-looking statements" within the meaning of legislation in the United Kingdom and/or United States. Such forward-looking statements include, but are not limited to, statements regarding the ability of Midatech to successfully commercialise any of its products. Any forward-looking statements are based on currently available competitive, financial and economic data together with management's views and assumptions regarding future events and business performance as of the time the statements are made and are subject to risks and uncertainties. We wish to caution you that there are some known and unknown factors that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. For a complete discussion of Risk Factors, please refer to the Company's Form 20-F Annual Report filing to be found at www.midatechpharma.com/investors/financial-reports.html

 

Reference should be made to those documents that Midatech shall file from time to time or announcements that may be made by Midatech in accordance with the London Stock Exchange AIM Rules for Companies ("AIM Rules"), the Disclosure and Transparency Rules ("DTRs") and the rules and regulations promulgated by the US Securities and Exchange Commission, which contains and identifies other important factors that could cause actual results to differ materially from those contained in any projections or forward-looking statements. These forward-looking statements speak only as of the date of this announcement. All subsequent written and oral forward-looking statements by or concerning Midatech are expressly qualified in their entirety by the cautionary statements above. Except as may be required under the AIM Rules or the DTRs or by relevant law in the United Kingdom or the United States, Midatech does not undertake any obligation to publicly update or revise any forward-looking statements because of new information, future events or otherwise arising.

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

NRAFBLLLQKFFBBX

Close

×

RNS Number : 0085K

Avanti Communications Group Plc

16 September 2016

 

This announcement contains Inside Information

CONTRACT WIN

ESA Contributes €10.7 Million to Deploy the Avanti ECO Wi-Fi Concept Across Africa

Avanti Communications Group plc ("Avanti"), a leading provider of satellite data communications services in Europe, the Middle East and Africa (EMEA), announces a new contract with the European Space Agency ("ESA") through its ARTES Partner programme. It will provide affordable satellite broadband connectivity to 1,400 community sites across Sub-Saharan Africa over the next two years  using Avanti's new ECO Wi-Fi hotspot initiative, launched today.

ESA will contribute up to €10.7 million in funding that Avanti will use to bring rural communities across Africa online. To deploy the advanced new technology platform, Avanti will partner with Newtec and a group of leading Service Providers, combining satellite, Wi-Fi and solar power , to deliver the programme in the market.

Memorandums of Understanding on ECO have been signed with the South African Ministry of Communications and Sentech in South Africa; Wananchi, Intersat and Imarasat in Kenya; and the Tanzania Education Authority. Many other governments, Service Providers and other Avanti partners have expressed support for the ECO initiative. This includes World Bank International Finance Corporation, Telkom Kenya, Internet Solutions, Safaricom, iWayAfrica, iSat Africa, MainOne, Nynex, TelOne, Quantis, Newtec and Discovery Learning Alliance.

Solar-powered ECO Wi-Fi hotspots will be hosted at schools that will benefit from subsidised Internet access. Consumers and local businesses, within range of the ECO Wi-Fi hotspot, will use the ECO mobile payment app (newly developed by Avanti) to make micropayments for broadband credits which convert to data usage.   

Magali Vaissiere, Director of Telecommunications and Integrated Applications at the European Space Agency (ESA), said: "As part of the ARTES Partner programme, we are excited to support and contribute to the ECO programme as it launches today. By doing so, ESA is investing in European ground infrastructure and fostering the delivery of satellite services in global markets. We look forward to working with Avanti in Sub-Saharan Africa to support better education outcomes and to unlock new business opportunities for both local Service Providers and European industry technology providers. Additionally we are happy  to provide a connectivity platform that   will ensure many long term NGO and Corporate Social Responsibility (CSR) initiatives are sustainable."

David Williams, Chief Executive Officer of Avanti, said: "Through product innovation and a partner strategy we have found an economically viable way to deliver broadband to low income customers in rural Africa. Working with governments and local service providers, and with support from ESA, this first project is a significant step towards creating something that will address a need across the entire continent."
 

For further information please contact:

ESA Media Relations Office, +33 1 53 69 72 99, media@esa.int 

Cenkos Securities (Nomad), Max Hartley,  Nicholas Wells, +44 207 397 8900

Avanti Investor Relations: Matthew Springett, +44 (0)207 749 6703

Montfort: Nick Miles / James Olley, +44 (0)203 770 7909

Redleaf: Hannah Nicolas, +44 (0)207 382 4734

Disclosure requirements of the Takeover Code

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 p.m. (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 p.m. (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 p.m. (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

Notes to Editors:

About Avanti Communications

Avanti connects people wherever they are – in their homes, businesses, in government and on mobiles. Through the HYLAS satellite fleet and more than 180 partners in 118 countries, the network provides ubiquitous internet service to a quarter of the world's population. Avanti delivers the level of quality and flexibility that the most demanding telecoms customers in the world seek.

Avanti is the first mover in high throughput satellite data communications in EMEA. It has rights to orbital slots and Ka-band spectrum in perpetuity that covers an end market of over 1.7bn people.

The Group has invested $1.2bn in a network that incorporates satellites, ground stations, datacentres and a fibre ring.

Avanti has a unique Cloud based customer interface that is protected by patented technology.

Avanti Communications is listed in London on AIM (AVN:LSE).

www.avantiplc.com 

 

ECO Wi-Fi hotspot initiative

ECO is a new sustainable digital inclusion initiative focused on providing affordable, superfast satellite broadband to schools and their local communities across Sub-Saharan Africa. ECO is short for Every Child Online. Avanti believes that ECO can deliver digital education to every excluded child in Africa.

CSR and government customers cover the costs of the ECOPOP (Wi-Fi hotspot) and the end user consumer pays bandwidth costs.

Solar-powered ECO Wi-Fi hotspots will be hosted at schools that will benefit from subsidised Internet access. These Wi-Fi hotspots will be connected to the Internet via the HYLAS satellite fleet.

Consumers and local businesses, within range of the ECO Wi-Fi hotspot, will also benefit from connectivity by using the ECO mobile app to make micropayments for broadband usage. More detail on ECO can be found at www.avantiplc.com/eco.

 

About the European Space Agency

The European Space Agency (ESA) provides Europe's gateway to space.

ESA is an intergovernmental organisation, created in 1975, with the mission to shape the development of Europe's space capability and ensure that investment in space delivers benefits to the citizens of Europe and the world.

ESA has 22 Member States: Austria, Belgium, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Luxembourg, the Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, Switzerland and the United Kingdom, of whom 20 are Member States of the EU.

ESA has established formal cooperation with seven other Member States of the EU. Canada takes part in some ESA programmes under a Cooperation Agreement.

By coordinating the financial and intellectual resources of its members, ESA can undertake programmes and activities far beyond the scope of any single European country. It is working in particular with the EU on implementing the Galileo and Copernicus programmes.

ESA develops the launchers, spacecraft and ground facilities needed to keep Europe at the forefront of global space activities.

Today, it develops and launches satellites for Earth observation, navigation, telecommunications and astronomy, sends probes to the far reaches of the Solar System and cooperates in the human exploration of space. Learn more about ESA at www.esa.int

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

CNTLAMTTMBJBTTF

Close

×

RNS Number : 6181J

EU Supply PLC

13 September 2016

 

13 September 2016

EU Supply plc

("EU Supply", the "Company" or the "Group")

 

Renewal of agreements

 

EU Supply (LSE AIM: EUSP), the e-procurement software provider, is pleased to announce that the Company has renewed its distribution agreement with CTM Solutions BV in the Netherlands for a minimum of 3 years. This agreement originates from 2007 and is on a revenue share basis. As part of the renewal, the Group will also deliver certain services for approximately €75,000.  

 

The Group has also received notice from the Minister for Public Expenditure and Reform in Ireland executing their option to extend the existing agreement between the parties until May 2020.

 

In addition, the Group has received an intention to award for a 3-year agreement (plus the option to extend for 1 year) with existing customer Fællesudbud Sjælland (a consortium comprising over 15 Danish municipalities). The intention to award also includes the option for additional municipalities to use the Group's CTM™ platform. This renewal confirms the Group's strong market position in Denmark.

 

Martin Kilbane, eProcurement Lead, Office of Government Procurement, commented 

"We are pleased with the service received from EU Supply in respect of their platform CTMTM. It has added significant value to public procurement for public sector bodies in Ireland. We now look forward to working with EU Supply for another 3 years to meet Ireland's needs in relation to electronic procurement and to be compliant with the European Union's procurement directives and National legislation."

 

 

 

FURTHER ENQUIRIES

EU Supply PLC Tel: 020 7127 4545 Thomas Beergrehn, CEO   Mattias Ström, CFO       Stockdale Securities Tel: 020 7601 6100 Tom Griffiths, David Coaten

 

A copy of this announcement is available at www.eu-supply.com.

 

Notes to Editors

EU Supply is the UK holding company of the EU Supply Group, a Sweden-based e-commerce business, which has an established, market-leading, multilingual e-procurement platform for esourcing, e-tendering and contract management, tailored for the highly regulated European public sector market.

Since 2006, the Group has invested heavily in employing specialist programmers to add functionality, legal compliance as required and security features to its Complete Tender Management™ ("CTM™") platform to ensure that the Group is ideally placed to secure new contracts with EU Member States and their Contracting Authorities. The platform is available in 16 different languages.

The Directors believe that the Group's CTM™ platform is one of the easiest to use and most functionally advanced solutions available in the market. The CTM™ platform is used by over 7,000 European public sector bodies in 9 EU/EEC Member States and has National Procurement System status in four Member States (the UK, Ireland, Norway and Lithuania).

The Company's shares were admitted to trading on AIM in November 2013. In August and September 2015, the Company raised a total of £2.061m (before expenses) through a placing of new shares and the issue of first and second tranches of Convertible Loan Notes to institutional and other investors.

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

AGRLLFIDAVIFLIR

Close

×

RNS Number : 1944I

Osirium Technologies PLC

26 August 2016

 

Osirium Technologies plc

 

("Osirium" or "Group")

 

Contract win with a leading global asset management company

 

Osirium Technologies plc (AIM: OSI.L), a UK based cyber-security software provider, is pleased to announce a significant contract win with a leading global asset management company.  The asset manager has over £300 billion of assets under management and offices in c.30 countries.

 

Under the terms of the contract, Osirium will deliver its full product offering of Privileged Account Management, Privileged Task Management and Privileged Session Recorder software modules to 3,000 devices. As part of the contract Osirium will also provide its consultancy services. The contract is expected to deliver a material financial contribution in the current year and will run over a three year term.   

 

David Guyatt, Chief Executive Officer, commented: "We are delighted to sign this major new customer within the financial services sector, which is testament to our position as a trusted and reliable partner to help protect a Company's critical IT assets from cyber-attacks.  This is the largest single contract negotiated in the Group's history and Osirium looks forward to working closely with our new partner to combine cyber security with task automation benefits."  

 

For further information:

Osirium Technologies plc	Tel: 44 (0) 118 324 2444
David Guyatt, Chief Executive Officer Rupert Hutton, Chief Financial Officer www.osirium.com
Panmure Gordon (UK) Limited (Nominated Adviser and Broker)	Tel: +44 (0) 20 7886 2500
Fred Walsh / Peter Steel / James Greenwood/ William Wickham – Corporate Finance Charles Leigh-Pemberton – Corporate Broking
Hollins Communications (Financial PR) Sarah Hollins	Tel: +44 (0) 7764 947137

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Market Abuse Regulation 596/2014 ("MAR").

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

CNTAKPDQCBKDQFB

Close

×

Neville Registrars is delighted to welcome LoopUp Group plc as the newest addtion to its list of client companies.

LoopUp™ is a Software-as-a-Service (SaaS) conferencing solution for remote enterprise meetings.

Further information can be found on the Company's website:http://loopup.com/enuk/

Close

×

RNS Number : 9541H

LoopUp Group PLC

24 August 2016

 

 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

 

 

24 AUGUST 2016

 

LoopUp Group PLC

("LoopUp" or the "Company")

Admission to Trading on AIM and First Day of Dealings

LoopUp Group PLC,  a global software-as-a-service ("SaaS") provider of remote meetings, is pleased to announce that Admission of its ordinary shares to trading on the AIM market of the London Stock Exchange will take place at 8.00am today, 24 August 2016.  Dealings in the ordinary shares will commence under the ticker LOOP, with ISIN GB00BYQP6S60.

 

Upon Admission, the Company will have a market capitalisation of approximately £40.8m, following a successful Placing with institutional and private investors of LoopUp Group ordinary shares, raising total gross proceeds of £8.5m at a Placing price of 100 pence.

 

The total number of voting rights in the Company with effect from 24 August 2016 will be 40,784,176. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Panmure Gordon (UK) Limited ("Panmure Gordon") is acting as Nominated Advisor and sole Broker to the Company.

 

Commenting on Admission, Steve Flavell, Co-Chief Executive Officer of LoopUp Group, commented:

"The completion of the IPO process marks an important and exciting milestone on LoopUp's journey as a UK-headquartered and internationally-minded technology company, and provides a significant catalyst for our continued growth. The reception from investors has been positive and encouraging, and reinforces our belief that our differentiated product, business model and plans for the future provide the foundation needed to deliver on our potential as a public company. Our focus will continue to be on delivering an exceptional product and service to our customers around the world, supported by the funds we've raised and emboldened by the faith our new shareholders have placed in us. These are exciting times."

 

The Company's AIM Admission Document can be viewed at: http://www.loopup.com/enuk/investors/documents

 

* * * * *

 

 

For further information please contact:

 

LoopUp Group PLC	via FTI Consulting, LLP
Steve Flavell, co-CEO
Michael Hughes, co-CEO
Panmure Gordon (UK) Limited	+44 (0) 207 886 2500
Fred Walsh / Alina Vaskina / William Wickham (Corporate Finance)
Erik Anderson / Amy Sarra (Corporate Broking)
FTI Consulting, LLP	+44 (0) 203 727 1000
Matt Dixon / Chris Lane / Roger Newby

 

Panmure Gordon, which is authorised and regulated by the Financial Conduct Authority, is acting for LoopUp and for no-one else in connection with the Placing and Admission and will not be responsible to anyone other than LoopUp for providing the protections afforded to clients of Panmure Gordon, or for providing advice in relation to the Placing and Admission or any matters referred to this announcement.

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCSEUFMDFMSELA

Close